![Steven Gelone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Gelone
Keine laufenden Positionen mehr
Profil
Steven P.
Gelone is the founder of Hula Therapeutics, Inc. Former jobs include Director-Clinical Pharmacology at GSK Plc from 2000 to 2002, Director-Medical Affairs at Vicuron Pharmaceuticals LLC from 2002 to 2003, Vice President-Clinical & Preclinical Development at Shire ViroPharma, Inc. from 2005 to 2014, Chief Development Officer at Nabriva Therapeutics GmbH from 2014 to 2017, President, Chief Operating Officer & Director at Nabriva Therapeutics Plc from 2021 to 2023, and Head-Clinical Research & Development at Spark Therapeutics, Inc. Education includes undergraduate and doctorate degrees from Temple University (Pennsylvania).
Aktive Positionen von Steven Gelone
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Steven Gelone
| Unternehmen | Position | Ende |
|---|---|---|
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Technik-/Wissenschafts-/F&E-Leiter | 30.06.2017 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 01.01.2014 |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
| GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 |
| SPARK THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Steven Gelone
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
